数字化医学影像学示教体会

医学影像学示教是将医学影像学理论知识与具体的医学影像学图像相结合的关键途径.数字化医学影像学示教方式可以更加直观和形象的展示医学影像学理论课所涉及的理论知识,让学生更容易理解,提高了教学质量和教学效果.     

医院医药信息资源数字化建设及整合

从医院图书馆数字化建设、临床信息系统建设、管理信息系统建设等方面介绍医院医药信息资源数字化建设内容,从标准、法律、人才等方面指出医药信息资源整合存在的问题及相应对策,阐明医药信息资源整合对领导决策、临床医疗、科研教学服务的重要意义。     

数字化个人体检信息管理系统设计与实现

设计开发数字化个人体检信息管理系统以完成对个人常规体检信息的管理,介绍系统结构设计、开发运行环境、功能模块及操作界面,该系统实现了个人体检信息数据的录入、存储、分析并给出体检建议,应用于实际取得很好的效果。     

数字化MSCT扫描及数据后处理技术对肝局灶性结节增生的研究

探讨应用数字化MSCT三期扫描及数据后处理技术对肝脏局灶性结节增生（focal nodular hyperplasia,FNH）的诊断及鉴别诊断的价值。经病理及临床证实FNH31例共36个病灶,进行MSCT三期增强扫描,并对19例21个病灶行后处理三维血管成像（MIP、MPR、VR、CPR）,分析病灶三期扫描及血管血流特征。发现36个FNH病灶增强方式为快进稍慢出型,其中26／36个（72．2％）病灶检出中央星状疤痕;三维血管成像可清晰显示FNH滋养供血动脉增粗、肿瘤染色均匀浓密、网格状及放射状分隔等特征性影像学表现。因此。MSCT平扫、三期增强扫描及数字化三维血管成像技术有助于提高FNH诊断准确率及与其他肝脏占位病变鉴别诊断能力。     

数字化手术室的研究与设计

目的:研究和设计适合我国国情的数字化和智能化手术室。方法:利用网络技术和高清视频实现对医疗设备的集中控制,并且将与手术相关的信息实时传输给手术参与者和手术观摩者。结果:手术过程中能集中的控制各相关设备并能与手术室外部实时交互。结论:此系统增强了手术室的环境安全,提高了手术的效率。     

全数字化乳腺摄影对临床不可触及乳腺癌的诊断价值

目的:通过分析研究临床不可触及乳腺癌的数字化钼铑双靶乳腺X线摄影影像表现,探讨其诊断价值。方法:回顾分析经临床和病理证实的临床不可触及乳腺癌33例,所有病例均行全数字化钼铑双靶乳腺X线机检查,常规体位包括:双侧乳腺均行头尾位、内外斜位摄片,必要时加照局部点压,或局部点压放大摄影。通过双侧乳腺图像对比,观察其影像学表现,然后统计分析其诊断价值。结果:单纯性钙化14例;致密小结节4例;不对称性局限性致密影3例;局部结构紊乱4例;其他5例,如乳头内陷及乳头后漏斗征,血管影迂曲、增多、增粗,皮肤增厚及皮下脂肪浑浊;无异常X线表现3例。结论:全数字化乳腺摄影在发现早期乳腺癌方面有不可替代的优势,特别是对临床不可触及的早期乳腺癌的发现具有重要价值。     

中医理论的学科特点及其现代化、数字化

中医理论的科学内涵与学科特点，决定了中医学是一门与西医学互补的生命科学学科，应使之继续独立发展，传统中医理论的现代化，核心是实现数字化表达，建立中医理论数字化体系，中医四诊的数字化及四诊相关辅助仪器的研究开发，是中医学，中医，中医院以及中药功效现代化的重要关键。     

Estimating the potential economic impact of the Wasfaty program on costs of antidiabetic treatment: An initiative for the digital transformation of health

IntroductionThe Saudi health care transformation is taking place through the implementation of many initiatives and programs to serve Saudi Vision 2030, which aims to improve health care services by focusing on digitalization and privatization. This study aimed to evaluate the economic impact of implementing the new digital health transformation initiative (Wasfaty service) on the health care budget using diabetes mellitus as an example.MethodsThis study presents a cost analysis evaluation following the implementation of the Wasfaty program during the period between 2017 and 2021. The study compared the pre-Wasfaty period and the Wasfaty period in terms of direct medical costs. Data sources were the Ministry of Health for pre-Wasfaty data and the National Unified Procurement Company, which runs the Wasfaty program, for Wasfaty data. The study focuses on diabetic medications for outpatients. This health economic evaluation used the cost per visit, and sensitivity analyses were conducted utilizing the cost per patient according to the prevalence of diabetes mellitus.ResultsAfter implementing the transformation using the Wasfaty service, the estimated annual mean cost savings per visit were USD 109.18 (SAR 409.43), and the cost savings per patient with a prevalence of 11% were USD 13.89 (SAR 52.1). The saving costs were USD 11,750,600 (SAR 44,064,750) for human resources and USD 97,473,469 (SAR 365,525,508) for pharmacies’ operation costs without including warehouse expenditures. The savings from the clinical decision support system preventing undesirable medication costs were estimated at USD 9,842,720 (SAR 36,910,201), and savings from the prevention of undesirable adverse events were estimated at USD 137,332,615 (SAR 514,997,308) for a 6% prediction. The total healthcare expenditure savings were USD 258,762,981 to 274,972,971 (SAR 970,361,178 ± 1,031,148,640).ConclusionsImplementing the new digitization and privatization initiatives (i.e., the Wasfaty program) as a result of the transformation in the health care sector had led to a significant reduction in health care expenditures and cost savings with respect to clinical and pharmacy services using diabetes mellitus as an example.